Reconsidering the role of PMRT in low to intermediate risk breast cancer: Applying results from previous standards of treatment in the current multimodal practice

Key Points

• This analysis reconsiders the role of PMRT based on previous standards, suggesting updated treatment approaches.
• Key findings indicate that PMRT may improve outcomes in specific breast cancer risk categories, with patient selection crucial.
• Assessment of treatment efficacy involved reviewing historical data on breast cancer management and outcomes across varying risks.
• The implications of this study may lead to refined guidelines for PMRT application in multimodal treatment, enhancing patient care.